Changes in postmenopausal hormone replacement therapy use among women with high cardiovascular risk

Angela Hsu, Andrea Card, Susan Xiaoqin Lin, Sean Mota, Olveen Carrasquillo, Andrew Moran

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

After randomized trials failed to support the use ofhormone replacement therapy (HRT) for preventing cardiovascular disease (CVD), HRT use for postmenopausalwomen declined. Our analysis of 1999-2000 and 2003-2004 National Health and Nutrition Surveys (NHANES) shows that HRT use decreased 19% (from 27.6 to 8.4%; P < .001) among women with CVD versus 3% (from 19.8 to 16.8%; P = .68) among low-risk women, suggestingthatmost of the drop in HRT use may be among women prescribed HRT as an unproven treatment to prevent CVD.

Original languageEnglish
Pages (from-to)2184-2187
Number of pages4
JournalAmerican Journal of Public Health
Volume99
Issue number12
DOIs
StatePublished - Dec 1 2009
Externally publishedYes

Fingerprint

Estrogen Replacement Therapy
Cardiovascular Diseases
Nutrition Surveys
Health Surveys
Therapeutics

ASJC Scopus subject areas

  • Public Health, Environmental and Occupational Health

Cite this

Changes in postmenopausal hormone replacement therapy use among women with high cardiovascular risk. / Hsu, Angela; Card, Andrea; Lin, Susan Xiaoqin; Mota, Sean; Carrasquillo, Olveen; Moran, Andrew.

In: American Journal of Public Health, Vol. 99, No. 12, 01.12.2009, p. 2184-2187.

Research output: Contribution to journalArticle

Hsu, Angela ; Card, Andrea ; Lin, Susan Xiaoqin ; Mota, Sean ; Carrasquillo, Olveen ; Moran, Andrew. / Changes in postmenopausal hormone replacement therapy use among women with high cardiovascular risk. In: American Journal of Public Health. 2009 ; Vol. 99, No. 12. pp. 2184-2187.
@article{5163872c6663411ba4d34a8503f51761,
title = "Changes in postmenopausal hormone replacement therapy use among women with high cardiovascular risk",
abstract = "After randomized trials failed to support the use ofhormone replacement therapy (HRT) for preventing cardiovascular disease (CVD), HRT use for postmenopausalwomen declined. Our analysis of 1999-2000 and 2003-2004 National Health and Nutrition Surveys (NHANES) shows that HRT use decreased 19{\%} (from 27.6 to 8.4{\%}; P < .001) among women with CVD versus 3{\%} (from 19.8 to 16.8{\%}; P = .68) among low-risk women, suggestingthatmost of the drop in HRT use may be among women prescribed HRT as an unproven treatment to prevent CVD.",
author = "Angela Hsu and Andrea Card and Lin, {Susan Xiaoqin} and Sean Mota and Olveen Carrasquillo and Andrew Moran",
year = "2009",
month = "12",
day = "1",
doi = "10.2105/AJPH.2009.159889",
language = "English",
volume = "99",
pages = "2184--2187",
journal = "American Journal of Public Health",
issn = "0090-0036",
publisher = "American Public Health Association Inc.",
number = "12",

}

TY - JOUR

T1 - Changes in postmenopausal hormone replacement therapy use among women with high cardiovascular risk

AU - Hsu, Angela

AU - Card, Andrea

AU - Lin, Susan Xiaoqin

AU - Mota, Sean

AU - Carrasquillo, Olveen

AU - Moran, Andrew

PY - 2009/12/1

Y1 - 2009/12/1

N2 - After randomized trials failed to support the use ofhormone replacement therapy (HRT) for preventing cardiovascular disease (CVD), HRT use for postmenopausalwomen declined. Our analysis of 1999-2000 and 2003-2004 National Health and Nutrition Surveys (NHANES) shows that HRT use decreased 19% (from 27.6 to 8.4%; P < .001) among women with CVD versus 3% (from 19.8 to 16.8%; P = .68) among low-risk women, suggestingthatmost of the drop in HRT use may be among women prescribed HRT as an unproven treatment to prevent CVD.

AB - After randomized trials failed to support the use ofhormone replacement therapy (HRT) for preventing cardiovascular disease (CVD), HRT use for postmenopausalwomen declined. Our analysis of 1999-2000 and 2003-2004 National Health and Nutrition Surveys (NHANES) shows that HRT use decreased 19% (from 27.6 to 8.4%; P < .001) among women with CVD versus 3% (from 19.8 to 16.8%; P = .68) among low-risk women, suggestingthatmost of the drop in HRT use may be among women prescribed HRT as an unproven treatment to prevent CVD.

UR - http://www.scopus.com/inward/record.url?scp=72249117178&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=72249117178&partnerID=8YFLogxK

U2 - 10.2105/AJPH.2009.159889

DO - 10.2105/AJPH.2009.159889

M3 - Article

VL - 99

SP - 2184

EP - 2187

JO - American Journal of Public Health

JF - American Journal of Public Health

SN - 0090-0036

IS - 12

ER -